Phase I study with combination therapy of pirarubicin, etoposide, and vincristine in small-cell lung cancer.

vincristine therapy in small cell lung cancer.

Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.

Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Carboplatin and etoposide in advanced lung cancer:--a phase I study.

Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancer.

Vincristine, doxorubicin and cyclophosphamide with and without etoposide in limited small cell lung cancer.

Clinical experiences with platinum and etoposide therapy in lung cancer.

Phase II study of pirarubicin in metastatic breast cancer.

$Phase I-II study of high-dose etoposide in patients with refractory breast cancer.$
Phase I-II study of high-dose etoposide in patients with refractory breast cancer.

Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.

Epirubicin weekly in combination chemotherapy with cyclophosphamide and vincristine in untreated small cell lung cancer: a phase II trial.

Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.

Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.

II Study Group of the Association for Medical Oncology of the German Cancer Society.

A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer.

$A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer.$
A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer.

Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.

etoposide therapy in non-small cell lung cancer.

oral etoposide therapy in non-small cell lung cancer.

Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.

Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation.

Suggest Documents

vincristine therapy in small cell lung cancer.

Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.

Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Carboplatin and etoposide in advanced lung cancer:--a phase I study.

Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancer.

Vincristine, doxorubicin and cyclophosphamide with and without etoposide in limited small cell lung cancer.

Clinical experiences with platinum and etoposide therapy in lung cancer.

Phase II study of pirarubicin in metastatic breast cancer.

Phase I-II study of high-dose etoposide in patients with refractory breast cancer.

Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.

Epirubicin weekly in combination chemotherapy with cyclophosphamide and vincristine in untreated small cell lung cancer: a phase II trial.

Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.

Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.

II Study Group of the Association for Medical Oncology of the German Cancer Society.

A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer.

A phase I study of split-dose cisplatin and etoposide with concurrent accelerated hyperfractionated thoracic radiotherapy in elderly patients with limited-disease small cell lung cancer.

Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.

etoposide therapy in non-small cell lung cancer.

oral etoposide therapy in non-small cell lung cancer.

Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.

Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation.

Phase I study with combination therapy of pirarubicin, etoposide, and vincristine in small-cell lung cancer.

Recommend Documents

Follow Us